Fulgent Genetics, Inc. financial data

Symbol
FLGT on Nasdaq
Industry
Services-Medical Laboratories
Location
4399 Santa Anita Ave, El Monte, California
State of incorporation
Delaware
Fiscal year end
December 31
Former names
Fulgent Diagnostics, Inc. (to 7/15/2016)
Latest financial report
Q1 2024 - May 3, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 717 % +11.1%
Debt-to-equity 8.22 % -15.9%
Return On Equity -13.9 % -587%
Return On Assets -12.8 % -596%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 29.9M shares +0.75%
Common Stock, Shares, Outstanding 29.9M shares +0.67%
Entity Public Float 629M USD -35.7%
Common Stock, Value, Issued 3K USD 0%
Weighted Average Number of Shares Outstanding, Basic 29.8M shares +0.79%
Weighted Average Number of Shares Outstanding, Diluted 29.8M shares +0.79%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 288M USD -21.2%
Cost of Revenue 180M USD -18.9%
Research and Development Expense 43.1M USD +31.8%
Selling and Marketing Expense 40.4M USD -1.68%
General and Administrative Expense 88.7M USD -17.2%
Operating Income (Loss) -193M USD -299%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -167M USD -329%
Income Tax Expense (Benefit) 6.03M USD +93.7%
Net Income (Loss) Attributable to Parent -166M USD -540%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 54.7M USD -17.4%
Accounts Receivable, after Allowance for Credit Loss, Current 52.1M USD +19.5%
Other Assets, Current 28.8M USD -12%
Assets, Current 387M USD -33.4%
Property, Plant and Equipment, Net 86.7M USD +9.66%
Operating Lease, Right-of-Use Asset 9.23M USD -30.3%
Intangible Assets, Net (Excluding Goodwill) 141M USD -5.19%
Goodwill 22.1M USD -84.6%
Other Assets, Noncurrent 32.7M USD -27.9%
Assets 1.23B USD -10.7%
Accounts Payable, Current 19.6M USD -11.2%
Accrued Liabilities, Current 25.9M USD +22.9%
Contract with Customer, Liability, Current 2.76M USD +1.06%
Liabilities, Current 75.9M USD -7.31%
Deferred Income Tax Liabilities, Net 7.41M USD
Operating Lease, Liability, Noncurrent 6.58M USD -9.99%
Other Liabilities, Noncurrent 13.9M USD -13.5%
Liabilities 103M USD -4.27%
Accumulated Other Comprehensive Income (Loss), Net of Tax -1.1M USD +93.6%
Retained Earnings (Accumulated Deficit) 620M USD -21.1%
Stockholders' Equity Attributable to Parent 1.13B USD -10.6%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 1.13B USD -11.2%
Liabilities and Equity 1.23B USD -10.7%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 7.27M USD
Net Cash Provided by (Used in) Financing Activities -2.81M USD -155%
Net Cash Provided by (Used in) Investing Activities -47.2M USD -984%
Common Stock, Shares Authorized 50M shares 0%
Common Stock, Shares, Issued 32.7M shares +3.69%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -42.8M USD -221%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 54.7M USD -17.4%
Interest Paid, Excluding Capitalized Interest, Operating Activities 439K USD
Deferred Tax Assets, Valuation Allowance 15.9M USD +461%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 45.7M USD -19.2%
Operating Lease, Liability 9.49M USD -29.2%
Depreciation 17.4M USD -34.3%
Payments to Acquire Property, Plant, and Equipment 4.06M USD +99.4%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -150M USD -389%
Lessee, Operating Lease, Liability, to be Paid 10.5M USD -26.1%
Property, Plant and Equipment, Gross 134M USD +6.62%
Operating Lease, Liability, Current 2.91M USD -52.3%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.78M USD -16.1%
Lessee, Operating Lease, Liability, to be Paid, Year One 2.35M USD -42.3%
Operating Lease, Weighted Average Discount Rate, Percent 0.04 pure 0%
Deferred Income Tax Expense (Benefit) -557K USD +89.3%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 1.02M USD +25.3%
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.69M USD +10.8%
Deferred Tax Assets, Operating Loss Carryforwards 17.5M USD +7.04%
Preferred Stock, Shares Issued 0 shares
Deferred Federal Income Tax Expense (Benefit) -12.8M USD -239%
Current Income Tax Expense (Benefit) -10.3M USD -120%
Preferred Stock, Shares Authorized 1M shares 0%
Unrecognized Tax Benefits 5.98M USD -39.2%
Lessee, Operating Lease, Liability, to be Paid, Year Four 544K USD -60%
Preferred Stock, Shares Outstanding 0 shares
Current State and Local Tax Expense (Benefit) -4.72M USD -125%
Current Federal Tax Expense (Benefit) -5.59M USD -118%
Amortization of Intangible Assets 7.87M USD +4.08%
Depreciation, Depletion and Amortization 6.66M USD -3.14%
Deferred Tax Assets, Net of Valuation Allowance 29.8M USD -44.5%
Share-based Payment Arrangement, Expense 44.2M USD +18.5%
Deferred State and Local Income Tax Expense (Benefit) 4.1M USD
Interest Expense 498K USD +134%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%